Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study

Schizophr Res. 2011 Jul;129(2-3):169-71. doi: 10.1016/j.schres.2011.03.012. Epub 2011 Apr 2.

Abstract

The biological basis of the association between cannabis-induced dopamine dysregulation and psychosis remains poorly understood. This (123)I-IBZM SPECT study assessed striatal dopamine D2 receptor (D2R) binding in 37 untreated first-episode psychosis (FEP) subjects, and 18 healthy controls. The aim was to examine if there were differences between FEP subjects with (n=14) and without (n=23) cannabis use in uptake ratios in the D2R. Striatal/Frontal cortex (S/F) uptake ratios were obtained. Healthy controls showed the lowest D2R binding ratios. No differences were found in S/F ratios between users and non-users, suggesting similar dopaminergic mechanisms underlying psychotic symptoms in both groups.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Benzamides
  • Cannabis / metabolism*
  • Corpus Striatum / diagnostic imaging*
  • Dopamine Antagonists
  • Female
  • Humans
  • Male
  • Prospective Studies
  • Psychotic Disorders / diagnostic imaging*
  • Psychotic Disorders / metabolism
  • Psychotic Disorders / pathology*
  • Pyrrolidines
  • Receptors, Dopamine D2 / metabolism*
  • Statistics, Nonparametric
  • Tomography, Emission-Computed, Single-Photon
  • Young Adult

Substances

  • Benzamides
  • Dopamine Antagonists
  • Pyrrolidines
  • Receptors, Dopamine D2
  • 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide